Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy

Cancer statistics, 2023

Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Sarcopenia: revised European consensus on definition and diagnosis

Alfonso J. Cruz‐Jentoft, Gülistan Bahat, Jürgen M. Bauer et al. · Age and Ageing · 2018 · 14K citations · Full text

Medicine, Geriatric Medicine, Frailty +16

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

Medicine, Oncology, Pharmacology +13

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations

Medicine, Oncology, Pharmacology +13

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

Lisa Martin, Laura Birdsell, Neil Macdonald et al. · Journal of Clinical Oncology · 2013 · 2.7K citations

Medicine, Biostatistics, Oncology +17